Showing results (51-60 of 985) with videos related to
Sort By:
Pageof 99
Vaccine|August 7, 2017
Vaccines against Ebola virusNavin Venkatraman, Daniel Silman, Pedro M Folegatti, et al.The Journal of Pharmacy and Pharmacology|February 4, 2015
Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacyAdam A Walters, Christos Krastev, Adrian V S Hill, et al.European Journal of Human Genetics : EJHG|December 16, 2003
Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control studyAndrew J Walley, Christophe Aucan, Dominic Kwiatkowski, et al.The American Journal of Tropical Medicine and Hygiene|October 28, 2015
Modeling Combinations of Pre-erythrocytic Plasmodium falciparum Malaria VaccinesAndrew S Walker, José Lourenço, Adrian V S Hill, et al.Nature Reviews. Immunology|December 23, 2020
A guide to vaccinology: from basic principles to new developmentsAndrew J Pollard, Else M BijkerCurrent Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
Meningococcal vaccinesClare L Collins, Andrew J PollardThe Pediatric Infectious Disease Journal|September 13, 2007
Reconsideration of the use of meningococcal polysaccharide vaccineDan M Granoff, Andrew J PollardThe Lancet. Infectious Diseases|April 1, 2014
A vaccine against serogroup B Neisseria meningitidis: dealing with uncertaintySophie M Andrews, Andrew J PollardHuman Vaccines & Immunotherapeutics|April 18, 2012
Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?Christopher J A Duncan, Adrian V S Hill, Ruth D EllisClinical and Vaccine Immunology : CVI|December 30, 2011
Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccineCatrin E Moore, Branwen J Hennig, Kirsten P Perrett, et al.Pageof 99